Reply to Preoperative BRAF(V600E) mutation screening is unlikely to alter initial surgical treatment of patients with indeterminate thyroid nodules: A prospective case series of 960 patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|7|1084-1084

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.7, 2014-04, pp. : 1084-1084

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preoperative BRAF(V600E) mutation screening is unlikely to alter initial surgical treatment of patients with indeterminate thyroid nodules: A prospective case series of 960 patients

By  

CANCER, Vol. 120, Iss. 7, 2014-04 ,pp. : 1083-1084

John Wiley & Sons Inc

Access to resources Recommend Favorite

BRAF Mutation (V600E) Prevalence in Mexican Patients Diagnosed with Melanoma

By  

Case Reports in Oncology, Vol. 9, Iss. 1, 2016-04 ,pp. : 241-245

Karger

Access to resources Recommend Favorite

Concomitant Oral and Intravenous Pharmacokinetics of Dabrafenib, a BRAF Inhibitor, in Patients with BRAF V600 Mutation‐Positive Solid Tumors

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 53, Iss. 9, 2013-09 ,pp. : 955-961

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cutaneous toxicities associated with vemurafenib therapy in 107 patients with BRAF V600E mutation‐positive metastatic melanoma, including recognition and management of rare presentations

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 4, 2015-10 ,pp. : 1024-1031

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic study of the BRAF gene reveals new variants and high frequency of the V600E mutation among Iranian ameloblastoma patients

By  

JOURNAL OF ORAL PATHOLOGY & MEDICINE, Vol. 47, Iss. 1, 2018-01 ,pp. : 86-90

John Wiley & Sons Inc

Access to resources Recommend Favorite